Feedback / Questions
entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
Entinostat: Regulatory approval for breast cancer in Q2 2021
(Syndax)
-
Feb 6, 2020 -
Corporate Presentation
Regulatory
http://ir.syndax.com/static-files/ec1ddcca-2728-4880-ae53-9900a088c844
Feb 6, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious